Trial · NCT01718509
Results by group92
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 92
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Change From Baseline in the Number of Binge Days Per Week at Visit 8 Which Spans Weeks 11/12 | PLACEBO | -2.26 | Standard Error 0.137 | Binge days per week | |
| Change From Baseline in the Number of Binge Days Per Week at Visit 8 Which Spans Weeks 11/12 | SPD489 | -3.92 | Standard Error 0.135 | Binge days per week | |
| Percent of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | PLACEBO | 42.9 | 95% Confidence Interval 35.5 to 50.2 | percentage of participants | |
| Percent of Participants With Improvement on Clinical Global Impression-Improvement (CGI-I) Scores | SPD489 | 86.2 | 95% Confidence Interval 81.1 to 91.3 | percentage of participants | |
| Percent of Participants With a 4-Week Cessation From Binge Eating | PLACEBO | 13.1 | 95% Confidence Interval 8.1 to 18.0 | percentage of participants | |
| Percent of Participants With a 4-Week Cessation From Binge Eating | SPD489 | 36.2 | 95% Confidence Interval 29.1 to 43.3 | percentage of participants | |
| Percent Change From Baseline in Body Weight (kg) at Week 12 | PLACEBO | -0.15 | Standard Error 0.353 | percentage change | |
| Percent Change From Baseline in Body Weight (kg) at Week 12 | SPD489 | -5.57 | Standard Error 0.350 | percentage change | |
| Change From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Score at Week 12 | PLACEBO | -7.42 | Standard Error 0.571 | units on a scale | |
| Change From Baseline in Yale-Brown Obsessive Compulsive Scale Modified for Binge Eating (Y-BOCS-BE) Total Score at Week 12 | SPD489 | -15.36 | Standard Error 0.563 | units on a scale | |
| Change From Baseline in Fasting Triglyceride Levels at Up to 12 Weeks | PLACEBO | 0.062 | Standard Error 0.0453 | mmol/L | |
| Change From Baseline in Fasting Triglyceride Levels at Up to 12 Weeks | SPD489 | -0.133 | Standard Error 0.0449 | mmol/L | |
| Change From Baseline In Fasting Total Cholesterol Levels at Up to 12 Weeks | PLACEBO | -0.126 | Standard Error 0.0460 | mmol/L | |
| Change From Baseline In Fasting Total Cholesterol Levels at Up to 12 Weeks | SPD489 | -0.204 | Standard Error 0.0456 | mmol/L | |
| Change From Baseline in Hemoglobin A1c Levels at Up to 12 Weeks | PLACEBO | -0.02 | Standard Error 0.017 | Percent | |
| Change From Baseline in Hemoglobin A1c Levels at Up to 12 Weeks | SPD489 | 0.01 | Standard Error 0.017 | Percent | |
| Binge Eating Response | PLACEBO | 1-week cessation | 23.9 | percentage of participants | |
| Binge Eating Response | SPD489 | 1-week cessation | 55.9 | percentage of participants | |
| Binge Eating Response | PLACEBO | Marked reduction | 13.4 | percentage of participants | |
| Binge Eating Response | SPD489 | Marked reduction | 22.8 | percentage of participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01718509/results